Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis

Area of Science:

• Endocrinology and Metabolism
• Biomedical Engineering
• Clinical Diagnostics

Background:

• Continuous glucose sensors (CGS) are crucial for managing type 1 diabetes.
• Accurate glucose monitoring is essential, especially during glycemic fluctuations.
• Evaluating CGS accuracy requires methods that account for both glucose levels and trends.

Purpose of the Study:

• To compare the clinical accuracy of FreeStyle Navigator and MiniMed CGMS.
• To assess sensor performance during both euglycemia and hypoglycemia.
• To utilize continuous glucose-error grid analysis (CG-EGA) for detailed accuracy assessment.

Main Methods:

• 16 individuals with type 1 diabetes participated.
• Hyperinsulinemic-euglycemic clamps were used to control blood glucose levels.
• Continuous glucose-error grid analysis (CG-EGA) quantified accuracy in euglycemic and hypoglycemic ranges.

Main Results:

• Overall correlation between CGS and reference glucose was similar (Navigator: r=0.84, CGMS: r=0.79).
• During euglycemia, both systems showed comparable accuracy (Navigator: 88.8% A+B, CGMS: 89.3% A+B).
• During hypoglycemia, the Navigator (82.4% A+B) was significantly more accurate than the CGMS (61.6% A+B).

Conclusions:

• Continuous glucose-error grid analysis (CG-EGA) is effective for comparing CGS accuracy.
• The FreeStyle Navigator exhibited superior clinical accuracy during hypoglycemia compared to the MiniMed CGMS.
• CG-EGA offers more detailed accuracy insights than traditional correlational analysis.